Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II

Journal of Virology

Volumn 70, Issue 7, 1996, Pages 4714-4723

  Ueda, Keiji ^a   Wei, Y U ^a   Ganem, Don ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; VIRUS DNA;

ANIMAL CELL; ARTICLE; BINDING SITE; ELECTROPHORETIC MOBILITY; ENHANCER REGION; GENE INSERTION; HEPATITIS VIRUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; VIRUS ACTIVATION; VIRUS TRANSCRIPTION;

EID: 0029888986     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.7.4714-4723.1996     Document Type: Article

References (75)

1. Agre, P., P. F. Johnson, and S. L. McKnight. 1989. Cognate DNA binding specificity retained after leucine zipper exchange between GCN4 and C/EBP. Science 246:922-926.
2. Antonucci, T., and W. Rutter. 1989. Hepatitis B virus promoters are regulated by the HBV enhancer in a tissue-specific manner. J. Virol. 63:579-585.
3. Bach, I., M.-G. Mattei, S. Cereghini, and M. Yaniv. 1991. Two members of an HNF1 homeoprotein family are expressed in human liver. Nucleic Acids Res. 19:3553-3559.
4. Carlsson, P., P. Eriksson, and G. Bjursell. 1990. Two nuclear proteins bind to the major positive element of the apolipoprotein B gene promoter. Gene 94:295-301.
5. Chen, S.-T., P. La Porte, and J.-K. Yee. 1993. Mutational analysis of hepatitis B virus enhancer. Virology 196:652-659.
6. Cleary, M. A., S. Stern, M. Tanaka, and W. Herr. 1993 Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment. Genes Dev. 7:72-83.
7. Cresenzo-Chaigne, J., A. Pillot, A. Lillienbaum, M. Levreno, and E. Elfassi. 1991. Identification of a strong enhancer element upstream of the pregenomic start site of the duck hepatitis B virus genome. J. Virol. 65:3882-3885.
8. Descombes, P., and U. Schibler. 1991. A liver-enriched transcriptional activator protein. LAP. and a transcriptional inhibitory protein. LIP. are translated from the same mRNA. Cell 67:569-579.
9. Elfassi, E. 1987. Broad specificity of the hepatitis B virus enhancer function. Virology 160:259-262.
10. 9a. Fourel, G., and M. Buendia. Personal communication.
11. Fourel, G., J. Couturier, Y. Wei, F. Apiou, P. Tiollais, and M.-A. Buendia. 1994. Evidence for long-range oncogene activation by hepadnavirus insertion. EMBO J. 13:2526-2534.
12. Fourel, G., C. Transy, B. C. Tennant, and M.-A. Buendia. 1992. Expression of the woodchuck N-myc2 retroposon in brain and liver tumors is driven by a cryptic N-myc promoter. Mol. Cell. Biol. 12:5336-5344.
13. Fourel, G., C. Trepo, L. Bougueleret, B. Henglein, A. Ponzelto, P. Tiollais, and M.-A. Buendia. 1990. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature (London) 347:294-298.
14. Frain, M., G. Swart, P. Monaci, A. Nicosia, S. Stampfli, K. Frank, and R. Cortese. 1989. The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell 59:145-157.
15. Ganem, D., and H. E. Varmus. 1987. The molecular biology of the hepatitis B virus. Annu. Rev. Biochem. 56:651-667.
16. Garcia, A. D., P. Ostapchuk, and P. Hearing. 1993. Functional interaction of nuclear factors EF-C, HNF-4, and RXRa with hepatitis B virus enhancer I. J. Virol. 67:3940-3950.
17. Hall, R. K., F. M. Sladek, and D. K. Granner. 1995. The orphan receptors COUP-TF and HNF-4 serve as accessory factors required for inductin of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoidsicoids. Proc. Natl. Acad. Sci. USA 92:412-416.
18. Hansen, L. J., B. C. Tennant, C. Seeger, and D. Ganem. 1993. Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses. Mol. Cell. Biol. 13:659-667.
19. 17a.Hearing, P. Personal communication.
20. Hu, K., and A. Siddiqui. 1991. Regulation of the hepatitis B virus gene expression by the enhancer element 1. Virology 181:721-726.
21. Jameel, S., and A. Siddiqui. 1986. The human hepatitis B virus enhancer requires trans-acting cellular factors for activity. Mol. Cell. Biol. 6:710-715.
22. Johnson, J. L., A. K. Raney, and A. McLachlan. 1995. Characterization of a functional hepatocyte nuclear factor 3 binding site in the hepatitis B virus nucleocapsid promoter. Virology 208:147-158.
23. Jones, K. A., J. T. Kadonaga, P. J. Rosenfeld, T. J. Kelly, and R. Tjian. 1987. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48:79-89.
24. Junker, M., P. Galle, and H. Schaller. 1987. Expression and replication of the hepatitis B virus genome under foreign promoter control. Nucleic Acids Res. 15:10117-10132.
25. Kemler, I., E. Bucher, K. Seipel, M. M. Muler-Immergluck, and W. Schaffner. 1991. Promoters with the octamer DNA motif (ATGCAAAAT) can he ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration. Nucleic Acids Res. 19:237-242.
26. Kemler, I., and W. Schaffner. 1990. Octamer transcription factors and the cell type-specificity of immunoglobulin gene expression. FASEB J. 4:1444-14449.
27. Kodama, K., N. Ogasawara, H. Yoshikawa, and S. Murakami. 1985. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses. J. Virol. 56:978-986.
28. Kuo, C. J., P. B. Conley, C.-L. Hsieh, U. Francke, and G. R. Crabtree. 1990. Molecular cloning, functional expression and chromosomal localization of mouse hepatocyte nuclear factor 1. Proc. Natl. Acad. Sci. USA 87:9838-9842.
29. Landschulz, W. H., P. F. Johnson, E. Y. Adashi, B. J. Graves, and S. L. McKnight. 1988. Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev. 2:786-800.
30. Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcription factor AP-1 interacts with TPA inducible enhancer element. Cell 49:741-752.
31. Liu, C., W. S. Mason, and J. B. E. Burch. 1994. Identification of factor-binding sites in the duck hepatitis B virus enhancer and in vivo effects of enhancer mutations. J. Virol. 68:2286-2296.
32. Lopez-Cabrera, M., J. Letovsky, K.-Q. Hu, and A. Siddiqui. 1991. Transcriptional factor C/EBP binds to and transactivates the enhancer II clement of the hepatitis B virus. Virology 183:825-829.
33. Mendel, D. B., and G. R. Crabtree. 1991. HNF-1, a member of a novel class of dimerizing homeodomain proteins. J. Biol. Chem. 266:677-680.
34. Mendel, D. B., L. P. Hansen, M. K. Graves, P. B. Conley, and G. R. Crabtree. 1991. HNF1a and HNF1b (vHNF1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev. 5:1042-1052.
35. Mendelzon, D., F. Boissier, and M. M. Zakin. 1990. The binding site for the liver-specific transcription factor Tf-LF1 and the TATA box of the human transferrin gene promoter are the only elements necessary to direct liver-specific transcription in vitro. Nucleic Acids Res. 18:5717-5721.
36. Miura, N., and K. Tanaka. 1993. Analyses of the hepatocyte nuclear factor (HNF) 1 gene promoter: synergistic activation by HNF4 and HNF1 proteins. Nucleic Acids Res. 21:3731-3736.
37. Ori, A., D. Atzmony, I. Haviv, and Y. Shaul. 1994. An NF1 motif plays a central role in hepatitis B virus enhancer. Virology 204:600-608.
38. Ori, A., and Y. Shaul. 1995. Hepatitis B virus enhancer binds and is activated by the hepatocyte nuclear factor 3. Virology 207:98-106.
39. Ostapchuck, P., G. Schierle, and P. Hearing. 1989. Binding of nuclear factor EF/C to a functional domain of the hepatitis B virus enhancer region. Mol. Cell. Biol. 9:2787-2797.
40. Pearson, W. R., and D. J. Lipman. 1988. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA 85:2444-2448.
41. Perez-Mutul, J. M. M., and B. Wasylyk. 1988. Mutational analysis of the contribution of sequence motifs within the IgH enhancer to tissue specific transcriptional activation. Nucleic Acids Res. 16:6085-6096.
42. Popper, H., L. Roth, R. Purcell, B. Tennant, and J. Gerin. 1987. Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc. Natl. Acad. Sci. USA 84:866-870.
43. Raney, A., A. Easton, D. Milich, and A. McLachlan. 1991. Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and prolinerich domain of hepatocyte nuclear factor I. J. Virol. 65:5774-5781.
44. Rey-Coampos, J., T. Chouard, M. Yaniv, and S. Cereghini. 1991. vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. EMBO J. 10:1445-1457.
45. Robinson, W. S. 1994. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annu. Rev. Med. 45:297-323.
46. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
47. Seeger, C., B. Baldwin, and B. C. Tennant. 1989. Expression of infectious woodchuck hepatitis virus in murine and avian fibroblasts. J. Virol. 63:4665-4669.
48. Seeger, C., B. Baldwin, W. E. Hornbuckle, A. E. Yeager, B. C. Tennant, P. Cote, L. Ferrell, D. Ganem, and H. E. Varmus. 1991. Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in common host. J. Virol. 65:1673-1679.
49. Shaul, J., W. Rutter, and O. Laub. 1985. A human hepatitis B virus enhancer element. EMBO J. 4:427-430.
50. Siegrist, C. A., B. Durand, P. Emery, E. David, P. Hearing, B. Mach, and W. Reith. 1993. RFX1 is identical to enhancer factor C and functions as transactivator of the hepatitis B virus enhancer. Mol. Cell. Biol. 13:6375-6384.
51. Sladek, F. M., W. Zhong, E. Lai, and J. E. Darnell, Jr. 1990. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4:2353-2365.
52. Sourdive, D. J. D., T. Chouard, and M. Yaniv. 1993. The HNF1 C-terminal domain contributes to transcriptional activity and modulates nuclear localisation. C. R. Acad. Sci. Paris 316:385-394.
53. Stern, S., and W. Herr. 1991. The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain. Genes Dev. 5:2555-2566.
54. Strum, R. A., G. Das, and W. Herr. 1988. The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev. 2:1582-1599.
55. Su, H., and J.-K. Yee. 1992. Regulation of hepatitis B virus gene expression by its two enhancers. Proc. Natl. Acad. Sci. USA 89:2708-2712.
56. Tanaka, M., and W. Herr. 1990. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60:375-386.
57. Tanaka, M., J.-J. Lai, and W. Herr. 1992. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell 68:755-767.
58. Theisen, M., R. R. Behringer, G. G. Cadd, R. L. Brinster, and G. S. McKnight. 1993. A C/EBP-binding site in the transferrin promoter is essential for expression in the liver but not the brain of transgenic mice. Mol. Cell. Biol. 13:7666-7676.
59. Tognoni, A., R. Catteneo, E. Serfling, and W. Schaffner. 1985. A novel selection approach allows precise mapping of the hepatitis B virus enhancer. Nucleic Acids Res. 13:7457-7471.
60. 57a. Trujillo, A., J. Chang, and V. Wei. Unpublished data.
61. Trujillo, M., J. Letovsky, H. Maguire, M. Lopez-Cabrera, and A. Siddiqui. 1991. Functional analysis of a liver-specific enhancer of the hepatitis B virus. Proc. Natl. Acad. Sci. USA 88:3797-3801.
62. Tsai, S. Y., I. Sagami, H. Wang, M.-J. Tsai, and B. W. O'Malley. 1987. Interactions between a DNA-hinding transcription factor (COUP) and a non-DNA binding factor (S300-II). Cell 50:701-709.
63. Ueda, K., Y. Wei and D. Ganem. 1996. Activation of N-myc2 gene expression by cis-acting elements of oncogenic hepadnaviral genomes: key role of enhancer II. Virology 217:413-417.
64. Valenzuela, P., L. Rall, M. Zaldivar, M. Quiroga, P. Gray, and W. Rulter. 1980. The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes. ICN-UCLA Symp. Mol. Cell. Biol. 18:57-70.
65. Vannice, J., and A. Levinson. 1988. Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity. J. Virol. 62:1305-1313.
66. Wang, L.-H., S. Y. Tsai, R. G. Cook, W. G. Beattie, M.-J. Tsai, and B. W. O'Malley. 1989. COUP transcription factor is a member of the steroid receptor superfamily. Nature (London) 340:163-166.
67. Wei, Y., G. Fourel, A. Ponzetto, M. Silvestro, P. Tiollais, and M.-A. Buendia. 1992. Hepadnavirus integration: mechanisms of activation of the N-mvc2 retrotransposon in woodchuck liver tumors. J. Virol. 66:5265-5276.
68. Wijnholds, J., J. Philipsen, and A. Geert. 1988. Tissue-specific and steroid-dependent interaction of transcription factors with the oestrogen-inducible apoVLDL II promoter in vivo. EMBO J. 7:2757-2763.
69. Williams, S. C., C. A. Cantwell, and P. F. Johnson. 1991. A family of C/EBP-related proteins capable of forming covalently linked lucine zipper dimers in vitro. Genes Dev. 5:1553-1567.
70. Yee, J.-K. 1989. A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science 246:658-661.
71. Yen, T.-S. B., 1993. Regulation of hepatitis B virus gene expression. Semin. Virol. 4:33-42.
72. Yuh, C.-H., Y.-L. Chang, and L.-P. Ting. 1992. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J. Virol. 66:4073-4084.
73. Yuh, C.-H., and L.-P. Ting. 1990. The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function. J. Virol. 64:4281-4287.
74. Yuh, C.-H., and L.-P. Ting. 1991. CVEBP-like proteins binding to the functional box-a and box-b of the second enhancer of hepatitis B virus. Mol. Cell. Biol. 11:5044-5052.
75. Yuh, C.-H., and L.-P. Ting. 1993. Differentiated liver cell specificity of the second enhancer of the hepatitis B virus. J. Virol. 67:142-149.